by Daniela Sanchez | Nov 8, 2019 | Commentary |
What do WeWork, Lyft, and Smile Direct Club have in common? They are “tech companies,” their IPOs underperformed or didn’t happen at all, and they all hired JP Morgan as their underwriter. What is an Underwriter? When a company is planning to go public, they...
by Laura Kirtley | Nov 6, 2019 | Commentary |
From the transferability of social media or email accounts to maintaining online accounts linked to a client’s virtual assets, estate planning issues regarding digital assets have existed for some time. But, now that blockchain based assets such as cryptocurrencies...
by Brenna Gibbs | Oct 30, 2019 | Commentary |
While video manipulation has been around since before Tom Hanks was shown meeting with President John F. Kennedy 31 years after his assassination in Forrest Gump, there has been a recent proliferation of a more sinister use of editing technology. The term “deepfake”...
by Carlino Mark Natividad | Oct 30, 2019 | Commentary |
Do you ever receive an incoming call on your cell phone only to see it’s coming from a “Scam Likely”? Robocalls, or automated phone calls usually for scam or spam purposes, have risen to approximately 85 billion calls worldwide in 2018 according to the Hiya...
by Yana Nebuchina | Oct 23, 2019 | Commentary |
Cannabidiol (CBD) has the potential to be big business. Since the descheduling of hemp-derived CBD, large corporations have been exploring how they might capitalize on CBD’s hold on the public’s attention. CVS and Walgreens announced their rollout of CBD products in...
by Lin Sun | Sep 8, 2019 | Commentary |
I first learned of CAR-T cell therapy in 2015 while working in an immunology lab. It immediately caught my attention as a brilliant, unconventional cancer treatment: it modifies a patient’s own T cells and enlists them to fight cancer. T cells can recognize non-self...
